losartan has been researched along with Paraganglioma in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Paraganglioma: A neural crest tumor usually derived from the chromoreceptor tissue of a paraganglion, such as the carotid body, or medulla of the adrenal gland (usually called a chromaffinoma or pheochromocytoma). It is more common in women than in men. (Stedman, 25th ed; from Segen, Dictionary of Modern Medicine, 1992)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Novosel, A | 1 |
| Heger, A | 1 |
| Lohse, P | 1 |
| Schmidt, H | 1 |
1 other study available for losartan and Paraganglioma
| Article | Year |
|---|---|
Multiple pheochromocytomas and paragangliomas in a young patient carrying a SDHD gene mutation.
Topics: Abdominal Neoplasms; Adolescent; Adrenal Gland Neoplasms; Adrenalectomy; Angiotensin II Type 1 Recep | 2004 |